Akebia Therapeutics, Inc.

Charlotte Suzanne Hartman

Alexander Smith

Gurudatt Ajay Chandorkar

Ene Ikpong Ette

Ramin Farzaneh-Far

Bradley John Maroni

Jula Kern Inrig

John M Janusz

Robert A Shalwitz

Joseph H Gardner

Akshay Buch

Isaiah Shalwitz

Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia associated with or resulting from chemotherapy, or anemia associated with AIDS.

Compositions and methods for treating anemia

Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia secondary to or associated with non-dialysis dependent chronic kidney disease anemia associated with or resulting from chemotherapy, or anemia associated with AIDS.

Growing community of inventors

Carmel, IN, United States of America

Charlotte Suzanne Hartman